These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 26877111)

  • 1. [Update on the control of patients on treatment with vitaminK antagonist oral anticoagulants in Primary Care].
    Fernández López P; López Ramiro MI; Merino de Haro I; Cedeño Manzano G; Díaz Siles FJ; Hermoso Sabio A
    Semergen; 2016; 42(8):530-537. PubMed ID: 26877111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Quality control of oral anticoagulant therapy in Primary Care in Madrid City, Spain: CHRONOS-TAO study].
    Alonso Roca R; Figueroa Guerrero CA; Mainar de Paz V; Arribas García MP; Sánchez Perruca L; Rodríguez Barrientos R; Casado López M; Pedraza Flechas AM
    Med Clin (Barc); 2015 Sep; 145(5):192-7. PubMed ID: 25433789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality control of oral anticoagulation with vitamin K antagonists in primary care patients in Poland: a multi-centre study.
    Sawicka-Powierza J; Buczkowski K; Chlabicz S; Gugnowski Z; Powierza K; Ołtarzewska AM
    Kardiol Pol; 2018; 76(4):764-769. PubMed ID: 29313558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticoagulation Control in Patients With Nonvalvular Atrial Fibrillation Attended at Primary Care Centers in Spain: The PAULA Study.
    Barrios V; Escobar C; Prieto L; Osorio G; Polo J; Lobos JM; Vargas D; García N
    Rev Esp Cardiol (Engl Ed); 2015 Sep; 68(9):769-76. PubMed ID: 26169326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of the Quality of Chronic Anticoagulation Control With Time in Therapeutic Range in Atrial Fibrillation Patients Treated With Vitamin K Antagonists by Hemostasis Specialists: The TERRA Registry: Tiempo en rango en la República Argentina.
    Tajer C; Ceresetto J; Bottaro FJ; Martí A; Casey M;
    Clin Appl Thromb Hemost; 2017 Jul; 23(5):445-453. PubMed ID: 26739542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Use of non-vitamin K antagonist oral anticoagulants in Primary Care: ACTUA study].
    Barrios V; Escobar C; Lobos JM; Polo J; Vargas D
    Semergen; 2017 Oct; 43(7):477-485. PubMed ID: 28029563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Descriptive analysis of the process and quality of oral anticoagulation management in real-life practice in patients with chronic non-valvular atrial fibrillation: the international study of anticoagulation management (ISAM).
    Ansell J; Hollowell J; Pengo V; Martinez-Brotons F; Caro J; Drouet L
    J Thromb Thrombolysis; 2007 Apr; 23(2):83-91. PubMed ID: 17221328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality of vitamin K antagonist oral anticoagulation in 322 patients with atrial fibrillation - real-life data from a survey in Eastern Switzerland.
    Maeder MT; König T; Bogdanovic S; Schneider I; Eugster W; Ammann P; König M; Beer J; Rickli H
    Swiss Med Wkly; 2017; 147():w14503. PubMed ID: 29039622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics and management of patients with stroke and major hemorrhagic episodes with atrial fibrillation under vitamin K antagonist therapy. EVENTHO study.
    Gavín O; Roldán V; Llamas-Sillero P; Santamaría A; Arumí D; Cabo SF
    Med Clin (Barc); 2022 Oct; 159(8):366-371. PubMed ID: 35120766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Level of control and treatment adherence of anticoagulation with acenocoumarol in Primary Care].
    Precioso Costa FJ; Larré Muñoz MJ; Navarro Ros FM; Silvero YA; Garrido Sepúlveda L; Llisterri Caro JL
    Semergen; 2016 Sep; 42(6):363-9. PubMed ID: 26602939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences among western European countries in anticoagulation management of atrial fibrillation. Data from the PREFER IN AF registry.
    Le Heuzey JY; Ammentorp B; Darius H; De Caterina R; Schilling RJ; Schmitt J; Zamorano JL; Kirchhof P
    Thromb Haemost; 2014 May; 111(5):833-41. PubMed ID: 24651882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Control of anticoagulation in patients with non-valvular atrial fibrillation in a primary care clinical practice setting in the different autonomous communities. PAULA study].
    Polo García J; Barrios Alonso V; Escobar Cervantes C; Prieto Valiente L; Lobos Bejarano JM; Vargas Ortega D; Prieto Díaz MÁ; Alonso Moreno FJ; Barquilla García A
    Semergen; 2017 Apr; 43(3):207-215. PubMed ID: 27422774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of time in therapeutic range in anticoagulated patients: a single-center, retrospective, observational study.
    Caldeira D; Cruz I; Morgado G; Stuart B; Gomes C; Martins C; João I; Pereira H
    BMC Res Notes; 2014 Dec; 7():891. PubMed ID: 25491419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of oral anticoagulation with vitamin K antagonists in 'real-world' patients with atrial fibrillation: a report from the prospective multicentre FANTASIIA registry.
    Esteve-Pastor MA; Rivera-Caravaca JM; Roldán-Rabadán I; Roldán V; Muñiz J; Raña-Míguez P; Ruiz-Ortiz M; Cequier Á; Bertomeu-Martínez V; Badimón L; Anguita M; Lip GYH; Marín F;
    Europace; 2018 Sep; 20(9):1435-1441. PubMed ID: 29095971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the impact of warfarin time in therapeutic range on outcomes of patients with atrial fibrillation in Turkey: perspectives from the observational, prospective WATER Registry.
    Turk UO; Tuncer E; Alioglu E; Yuksel K; Pekel N; Ozpelit E; Vuran O; Tengiz I
    Cardiol J; 2015; 22(5):567-75. PubMed ID: 26100825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A simple method to identify patients on long-term warfarin who may derive the most benefit from new oral anticoagulants.
    Carrier M; Kimpton M; Wells PS; Langlois N; Kherani S; Le Gal G
    Blood Coagul Fibrinolysis; 2014 Dec; 25(8):812-5. PubMed ID: 24914740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The HIPOGAIA study: Monitoring of oral anticoagulation with vitamin K antagonists in the municipality of Gaia.
    Guedes M; Rego C
    Rev Port Cardiol; 2016 Sep; 35(9):459-65. PubMed ID: 27503590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of the quality control of anticoagulation in patients with atrial fibrillation in a Primary Health Care Area of Madrid].
    Habashneh Sánchez S; Abad Díaz I; Tinajero Valle CP; Cortés Palmero A; Lobón Agúndez MC; Muñoz Fernández C
    Semergen; 2016; 42(5):287-92. PubMed ID: 26272881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prevalence of oral anticoagulation and quality of its management in primary healthcare: A study by the Health Sentinel Network of the Region of Valencia (Spain)].
    Boned-Ombuena A; Pérez-Panadés J; López-Maside A; Miralles-Espí M; Guardiola Vilarroig S; Adam Ruiz D; Zurriaga O
    Aten Primaria; 2017 Nov; 49(9):534-548. PubMed ID: 28408116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral anticoagulant treatment in atrial fibrillation: the AFIRMA real-world study using natural language processing and machine learning.
    Cosín-Sales J; Anguita M; Suárez C; Arias-Cabrales C; Martínez-Sanchez L; ; Arumi D; Fernández de Cabo S
    Rev Clin Esp (Barc); 2024; 224(7):428-436. PubMed ID: 38849073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.